- 60 killed in Colombia guerilla violence
- 'Invincible' Gauff revels in Melbourne heat to reach quarters
- Indonesia's Mount Ibu erupts more than 1,000 times this month
- Sumo to stage event in Paris as part of global push
- Deadly strikes on Gaza after Israel says ceasefire delayed
- Badosa 'loves Coco' but is gunning for 'revenge' in Melbourne quarters
- Sabalenka, Gauff on Melbourne collision course as Alcaraz moves on
- Alcaraz into Australian Open quarters after Draper retires
- Sabalenka uses fighting spirit to banish Australian Open blues
- Sabalenka, Gauff on Melbourne collision course after reaching quarters
- Swiss rider Ruegg wins opening UCI World Tour event in Australia
- Mitchell scores 36 as Cavs bounce back, Celtics downed
- Sabalenka a happy snapper at Australian Open
- Gauff turns up heat on Bencic to reach Australian Open quarters
- Commanders stun Lions in NFL thriller, Chiefs advance
- Protesters storm S. Korea court after president's detention extended
- TikTok notifies US users of shutdown as Trump seeks last-ditch solution
- Ceasefire in Israel-Hamas war to begin at 0630 GMT
- Wuhan keen to shake off pandemic label five years on
- Sabalenka imperious as Djokovic, Alcaraz on Melbourne collision course
- 'Generational problem': Youth still struggling in pandemic's shadow
- Vaccine misinformation: a lasting side effect from Covid
- Sabalenka blows away Andreeva to reach Melbourne quarter-finals
- Hope, fear at Paris rally for Gaza hostages
- Separated by LA wildfires, a happy reunion for some pets, owners
- France's Moutet 'collapsed in shower' before Australian Open match
- In US, teleworkers don't want to turn back
- Covid's origins reviewed: Lab leak or natural spillover?
- Trump arrives in Washington ahead of Monday's inauguration
- Steady Straka takes four-shot lead in PGA Tour's American Express
- Kelce, Mahomes double-act leads Chiefs past Texans in NFL playoffs
- Barcelona's Balde complains of racist abuse in Getafe draw
- Frustrated Barca fail to capitalise on Atletico La Liga slip
- More Kenyan police land in Haiti to bolster security mission
- McGlynn leads youthful USA to friendly win over Venezuela
- Barcelona stumble to frustrating Getafe draw in title setback
- Lukaku fires Napoli six points clear at Atalanta, Juve sink Milan
- Milder winds help LA firefighters as Trump vows to visit
- S. Korean court extends impeached president's detention, angering supporters
- Wirtz has Leverkusen on Bayern's heels to keep repeat title 'dream' alive
- Arsenal must take blame for Villa fightback: Arteta
- Nunez late show extends Liverpool's lead, Arsenal held by Aston Villa
- Russian attacks kill six across Ukraine, Kyiv says
- Northampton, Leinster claim Champions Cup pool top spots
- Arsenal's title bid rocked by Villa fightback
- Superb Wirtz keeps Leverkusen on pace with leaders Bayern
- Detention extended for S. Korea's impeached president
- Thousands attend funeral of Liberian ex-warlord Prince Johnson
- Barcola strikes as PSG fight back to beat Lens
- Juventus into Serie A Champions League spots with victory over AC Milan
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
N.Walker--AT